Categories
MENA Pakistan Press Releases

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – AFIB

NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Acutus Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Acutus Medical class action, go to https://rosenlegal.com/submit-form/?case_id=3255 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 18, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) a material percentage of the AcQMap systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, Acutus Medical’s products; (2) a material percentage of the AcQMap systems under evaluation had been installed in locations where Acutus Medical did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system’s operations; (3) as a result, Acutus Medical was in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements; (4) Acutus Medical’s management discussion and analysis was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on Acutus Medical’s 2021 financial results; and (5) Acutus Medical’s risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing Acutus Medical. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Acutus Medical class action, go to https://rosenlegal.com/submit-form/?case_id=3255 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

Categories
MENA Pakistan Press Releases

ROSEN, A TOP RANKED LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – FENC

NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the “Class Period”) of the important April 11, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Fennec Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Fennec Pharmaceuticals class action, go https://rosenlegal.com/submit-form/?case_id=3153 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Fennec Pharmaceuticals had not successfully remediated, and overstated its efforts to remediate, issues with the manufacturing facility of its drug product manufacturer for PEDMARK; (2) as a result, the U.S. Food and Drug Administration was unlikely to approve the Resubmitted PEDMARK New Drug Application (“NDA”); (3) accordingly, the regulatory and commercial prospects of the Resubmitted NDA were overstated; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Fennec Pharmaceuticals class action, go https://rosenlegal.com/submit-form/?case_id=3153 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

Categories
Africa MENA Pakistan Press Releases South Africa

Chinmay J. Upadhyat becomes Regional Vice President, South Asia for Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, announces that Chinmay J. Upadhyat has joined the Group as Regional Vice President, South Asia region.

Chinmay will be based in Nikkiso Cosmodyne India Private Ltd, their large manufacturing and competence center in Gujarat India.

This important addition to their management team is the result of growth in the market environment and is in line with the objectives of the Industrial Division of Nikkiso to better serve and support their customers in the Southern Asia Market.

Chinmay started his career in 1995 as a Production Engineer with Anup Engineering and Inductotherm India, then served as key account manager for ten years with Dresser Rand India. Since 2008 he has been Regional then Assistant General Manager for Burckhardt Compression India where he was responsible for sales and business development of new machines for the Indian market.

With his broad experience in the CNG, LNG, H2 and industrial gas markets in India, Chinmay will lead the Nikkiso Clean Energy & Industrial Gases sales and service teams in this important region and embark on a mission to deliver market share growth in a sustainable and profitable way.

“Chinmay will be a perfect addition to our management team with his proficiency in business development, equipment, service, aftermarket sales and market knowledge,” according to Emile Bado, Vice President, Sales & Business Development of the Group.

Chinmay has a Mechanical Engineering degree from Government Polytechnic, Ahmedabad, a Bachelor’s in Technology from JNRVD University, Rajasthan and an MBA from Sikkim Manipal University in Manipal.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information please visit www.cryoind.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Categories
MENA Pakistan Press Releases

Provation appoints Gulf Medical Company as exclusive partner in Saudi Arabia for its market-leading clinical productivity solution

Provation® MD allows clinicians around the world to quickly and accurately document procedures electronically for gastroenterology and respiratory procedures.

Jeddah, Saudi Arabia, and Minneapolis, Minn., USA, Feb. 24, 2022 (GLOBE NEWSWIRE) — Provation, the premier software provider of procedure documentation and clinical decision support solutions, today announced an exclusive partnership with Gulf Medical Company, Ltd., a market leader in medical device and software distribution. The partnership agreement allows Gulf Medical to sell and distribute the global Gold Standard of gastroenterology (GI) and respiratory procedure documentation software, Provation® MD, throughout the Kingdom of Saudi Arabia (KSA).

For more than 25 years, Provation has been a market leader in clinical productivity software. Every day, more than 15,000 physicians and endoscopists in over 5,000 healthcare facilities worldwide use its intuitive workflows, image capture, and deep medical content for gastroenterology and respiratory documentation. Provation MD integrates with existing hospital information systems to replace paper clinical documentation, while improving the consistency, accuracy, and efficiency of procedure notes.

“Gulf Medical looks to its partnership with Provation as a milestone in our diversification into the healthcare IT business stream, which aligns with the Saudi government’s 2030 vision for digitization and Gulf Medical’s vision in bringing the most innovative solutions to the Middle East since 1983,” said Mohamed A. Raouf, Director of Services and New Technologies at Gulf Medical. “As a market leader in its domain, Provation can shift our customers’ experience into a new era of facilitating electronic documentation and reporting and GI workflow management.”

Provation awarded the partnership to Gulf Medical because of its excellent reputation and strong customer relationships with both the private and public hospital sectors throughout the region.

“We are very excited to have Gulf Medical as the exclusive distributor of Provation MD in Saudi Arabia,” said Daniel Hamburger, CEO of Provation. “The Gulf Medical team knows the medical device and software needs of healthcare organizations in their region. This partnership will allow us to further expand Provation’s presence throughout the Kingdom, while empowering more clinicians and endoscopists with the tools they need to deliver quality healthcare for all.”

Gulf Medical plans to rapidly introduce Provation MD to leading healthcare facilities across the Kingdom of Saudi Arabia (KSA).

About Provation

Provation is a leading provider of healthcare software and SaaS solutions for clinical procedure reports, anaesthesia documentation, quality reporting, and more. Provation is best known globally for providing the Gold Standard for gastroenterology (GI) procedure documentation, Provation® MD, and #1 Best in KLAS anaesthesia information management system, Provation® iPro. Our purpose is to empower providers worldwide with the tools they need to deliver quality healthcare for all.

Provation serves more than 5,000 hospitals and health systems, surgery centres, and medical offices, and 700 physician groups worldwide. In 2021, Provation was acquired by Fortive Corporation, a Fortune 1000 company that builds essential technology and accelerates transformation in high-impact fields like workplace safety, engineering, and healthcare. For more information about our solutions, visit provationmedical.com.

About Gulf Medical Company, LTD

Gulf Medical Co. was founded in 1983 to bring the most innovative medical solutions to the Middle East. It is owned by Al-Naghi Group (since 1911) and it serves the medical field in different product lines, bringing many firsts in medical solutions to the region; with a core value that its service does not end at the award of a sale; but only begins at the award and continues for many years to come after, this is side by side to customers and patients. Learn more at www.gulfmedical.com.

Attachment

Tristan Galvan
Provation
612.313.1548
tristan.galvan@provationmedical.com

Eng. Hamza Sheikh
Gulf Medical Company
hamzasheikh@gulfmedical.com
Categories
Africa MENA Pakistan Press Releases South Africa

Standard Lithium and Lanxess Finalize Plan for First Commercial Lithium Project in Arkansas

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI) (FRA: S5L), an innovative technology and lithium project development company, has reached an agreement (the “Agreement”), dated February 23, 2022, with its strategic partner, LANXESS Corporation (“Lanxess”), that streamlines and expedites the plan for development of the first commercial lithium project in Arkansas, which is to be constructed at an operational Lanxess facility in El Dorado, Arkansas (the “Project”). Under the Agreement, Standard Lithium will control all development of the Project leading up to and including the completion of the Front End Engineering Design (“FEED”) study. Standard Lithium will hold, at a minimum, a 51% majority equity stake in the Project and may retain as much as 100% of the Project. The Company will also retain 100% ownership of its South West Arkansas Project, all its proprietary extraction technologies, relevant intellectual property and know-how.

Robert Mintak, CEO of Standard Lithium commented, “This agreement builds upon the successful working relationship that has been established between the companies. By entering into this Agreement, Standard Lithium takes ownership of the Project and its development timelines with a clear path towards delivering the first new commercial lithium production in the USA in over 50 years.1 We have already begun the process of engaging and integrating the strategic team members to make this project a success.  With the recent investment from our largest shareholder, Koch Strategic Platforms, we are fully funded to complete all planned Project milestones leading to a Definitive Feasibility Study, which is expected to be completed in Q4 2022”.

Key Highlights:

  • Standard Lithium will form an initially wholly-owned company (“Project Company”) that owns 100% of the Project during pre-FEED and FEED engineering studies (see news release dated January 20th, 2022). The FEED engineering will be used to produce a NI43-101 Definitive Feasibility Study (“DFS”) in Q4 2022;
  • Lanxess will, via a series of commercial agreements, provide the brine supply for the Project, the Project site lease, and rights of way, infrastructure, and other services for the Project;
  • Standard Lithium will provide a market fee-based license to the Project Company of its suite of intellectual property;
  • Standard Lithium is able to utilize its intellectual property, extraction technology and know-how at its 100% owned South West Arkansas Project, certain other sites in Arkansas and at all project sites outside of Arkansas, and will maintain control and ownership over the future development of its IP portfolio; and,
  • Lanxess is obliged to support development of the Project and upon completion of a DFS, has the option to acquire an equity interest in the Project Company of up to 49% and not less than 30%, at a price equal to a ratable share of SLL’s aggregate investment in the Project Company.

If Lanxess acquires an ownership interest:

  • The parties will share the costs of financing construction of the Project on a ratable basis; and,
  • Lanxess will have the right to acquire some, or all of the lithium carbonate off-take produced at the commercial plant at market-based terms less a handling fee.

If Lanxess does not acquire an ownership interest:

  • Standard Lithium will own 100% of the Project including customary dividends, distribution, or similar rights;
  • Standard Lithium can elicit bids from other interested parties to buy up to 49% of the Project Company; and,
  • Lanxess will have the right to acquire some, or all of the lithium carbonate off-take produced at the commercial plant at a price of market minus up to 20%, to be agreed by Lanxess and Standard Lithium and taking into consideration several key commercial agreements (including the costs of brine supply and disposal for the Project, the Project site lease cost and rights of way, infrastructure, and other services for the Project).

The parties have also agreed that development of the second and third projects on the Lanxess properties will be on a joint basis and that the parties will perform the same roles using similar contractual structures as the first Project. Lanxess will also have the right to purchase the lithium carbonate off-take from the additional projects upon market-based terms to be agreed by Lanxess and Standard Lithium, taking into consideration other commercial agreements required for their development (e.g. site leases, brine supply/disposal etc.).

Advisors
Stifel Nicolas Canada Inc. acted as financial advisor to Standard Lithium during negotiation of this Agreement.

About Standard Lithium Ltd.
Standard Lithium is an innovative technology and lithium development company. The Company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations. The Company operates its first-of-a-kind industrial-scale direct lithium extraction demonstration plant at Lanxess’s south plant facility in southern Arkansas. The demonstration plant utilizes the Company’s proprietary LiSTR technology to selectively extract lithium from Lanxess’s tail brine. The demonstration plant is being used for proof-of-concept and commercial feasibility studies. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. The Company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwest Arkansas, referred to as the South West Arkansas Lithium Project, and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California.

Standard Lithium is jointly listed on the TSX Venture Exchange and the NYSE American under the trading symbol “SLI”; and on the Frankfurt Stock Exchange under the symbol “S5L”. Please visit the Company’s website at http://www.standardlithium.com.

On behalf of the Board of Standard Lithium Ltd.
Robert Mintak, CEO & Director

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and other similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to expected development of the Project and future phases, the timeline for completion of the DFS, negotiation of definitive documentation with Lanxess, accuracy of mineral or resource exploration activity, reserves or resources, regulatory or government requirements or approvals, the reliability of third party information, continued access to mineral properties or infrastructure, fluctuations in the market for lithium and its derivatives, changes in exploration costs and government regulation in Canada and the United States, and other factors or information. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations.

1 See https://pubs.usgs.gov/periodicals/mcs2021/mcs2021-lithium.pdf

For further information contact:

LHA Investor Relations
David Barnard
+1 415-433-3777
standardlithium@lhai.com
info@standardlithium.com
Twitter: @standardlithium
LinkedIn: https://www.linkedin.com/company/standard-lithium/
Categories
MENA Pakistan Press Releases

Dante Labs selected as Genetic Tests provider for Abu Dhabi Executive Office Employee’s Wellbeing Week

Dante Labs meets with Abu Dhabi Executive Office

Dante Labs CEO Andrea Riposati and Carlo Logli meet with Dr. Fatima Al Kaabi, Director of Genome Office at Abu Dhabi Executive Office and team.

NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, is pleased to announce that the company has been selected as a genetic services provider for Abu Dhabi Executive Office (ADEO) employees for their wellbeing week.

Beginning on February 14, 2022, Dante will be providing whole genome sequencing to ADEO employees as part of the company’s benefit package for all employees.

The testing will be run in the new Dante Dubai laboratory and will provide employees with invaluable insights about their wellness and longevity, including risk of developing certain health conditions, evidence of intolerances to food, and indications for a personalized and balanced diet and fitness training.

“We are very proud to be increasing access to genomic sequencing through this great opportunity to provide our service to ADEO employees. It is through employee testing like this that we are able to deliver invaluable health insights to more people and ultimately better healthcare and longevity,” said Andrea Riposati, CEO of Dante Labs. “The UAE is clearly becoming a global leader in genomics, and we are thrilled to have invested in this amazing country.”

“Not only is this extremely exciting, but we are hopeful that testing programs such as these will pave the way to wider adoption of genomics in other fields such as R&D, training and development programs,” said Prof. Mattia Capulli, Chief Scientific Officer of Dante Labs.

“The Abu Dhabi Executive Office is extremely happy and appreciates Dante Labs for their great service that contributes to our employee’s wellbeing by providing the unique actionable benefit from genomics in both clinical and consumer settings from sports to nutrigenomics,” said Dr. Fatima Al Kaabi, Director of Genome Office, Abu Dhabi Executive Office.

About Dante Labs

Dante Labs is a global genomic data company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Contact

Laura D’Angelo
VP of Investor Relations
ir@dantelabs.com
+39 0862 191 0671
www.dantelabs.com

A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/95013cb8-6b11-4222-ab49-476331c160f3

Categories
Africa MENA Pakistan Press Releases South Africa

Zoom Introduces Category-Redefining Contact Center Solution

Zoom Contact Center sets new standards for customer service experiences through omnichannel, video-optimized interactions

SAN JOSE, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) — Today, Zoom Video Communications, Inc. (NASDAQ: ZM) announced Zoom Contact Center, an omnichannel contact center solution that is optimized for video and integrated right into the same Zoom experience. Now available, Zoom Contact Center, previously Zoom Video Engagement Center, combines unified communications and contact center capabilities with the useability of the Zoom platform. Zoom Contact Center supports customer service use cases and workflows using channels like video and voice, with SMS and webchat currently in beta.

The Zoom platform is powering the future of communications beyond meetings with unified communications, the Zoom Developer Platform, Zoom Events, and now Zoom Contact Center. These innovations – and there are many more – were created with the same level of scalability and simplicity that has made Zoom the trusted platform for more than a half-million businesses worldwide.

Innovation Through Video
Zoom Contact Center will have over 100 agent, supervisor, and contact center administrator features at launch. Future investments will include additional channels, CRM and workforce management integrations, and AI/ML to optimize agent productivity. At launch, Zoom Contact Center will extend traditional capabilities typically optimized for voice to provide a unique end customer experience through channels like video.

“Zoom understands the importance of bringing together UC and multichannel contact center into the same experience,” said Blair Pleasant of BCStrategies. “Zoom is known for great video, which is important for high-touch customer scenarios and internal use cases like IT help desk, employee helpline, and revenue-generating activities. But the fact that Zoom Contact Center supports routing, additional channels, and the agent functionality organizations need, means that Zoom Contact Center could become the modern contact center solution of choice.”

Enabling Connected Work From Anywhere
Contact center agents are frequently tied to physical contact center locations, and if able to work remotely, often still need to navigate multiple communications tools. Zoom Contact Center streamlines inefficiencies by bringing communications into one central hub. In addition to helping end customers with a rich agent experience, agents can collaborate with peers, supervisors, or other employees right in Zoom Chat and channels. Unified communications and contact center together empowers agents to be more productive from any location while feeling connected to the larger organization.

“Previously, contact center infrastructure was complex to deploy, expensive to operate, and time-intensive to upgrade. Zoom Contact Center was carefully designed to meet the needs of the modern agent and end customer, both of which expect a personalized, digital, and effective contact center experience,” said Oded Gal, Chief Product Officer of Zoom. “I am pleased to announce the general availability of Zoom Contact Center, building upon the reliable Zoom platform model and bringing the experiences our customers know and love to yet another industry.”

Ensuring Ease of Deployment and Use
Zoom Contact Center is simple for administrators to configure and deploy, including a graphical drag-and-drop IVR designer. Contact center administrators can easily create menus, greetings, and prompts right in the same Zoom Admin portal. Zoom Contact Center can also integrate chat and video into an existing digital presence, like a website, helping organizations have conversations with customers in the right context and at the right time.

“Our members trust us with their most privileged information, so when they need support, it is our responsibility to provide them with the expertise First Federal Credit Union is known for,” said Chris Neal, Senior Vice President Operations of First Federal Credit Union. “With Zoom Contact Center, our contact center supervisors have the ability to organize service representatives based on skills, so when a member reaches out, we can now route their inquiries directly to experts that are equipped to handle their unique needs. A process that would previously require multiple service representatives can now be accelerated and streamlined into a single conversation. We’ve seen our overall call time and pick-up time improve significantly as we provide more efficient resolution and a better experience for our members.”

Customer choice is an essential value of the Zoom platform. In addition to Zoom Contact Center, Zoom intends to maintain its valued existing contact center partnerships.

Zoom Contact Center is now available in the U.S. and CA, with more international availability coming later this year. To learn more about Zoom Contact Center, please visit the Zoom Contact Center page and read our blog.

About Zoom
Zoom is for you. Zoom is a space where you can connect to others, share ideas, make plans, and build toward a future limited only by your imagination. Our frictionless communications platform is the only one that started with video as its foundation, and we have set the standard for innovation ever since. That is why we are an intuitive, scalable, and secure choice for individuals, small businesses, and large enterprises alike. Founded in 2011, Zoom is publicly traded (NASDAQ: ZM) and headquartered in San Jose, California. Visit zoom.com and follow @zoom.

Press Relations
Farshad Hashmatulla
Product PR Manager
press@zoom.us

Categories
MENA Pakistan Press Releases

AIT, Qatar Investment Authority, Onex Announce Partnership

All amounts in U.S. dollars unless otherwise stated 

PLANO, Texas, DOHA, Qatar, and TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) — AIT (the “company”), together with its founding management and Onex Corporation (“Onex”) (TSX: ONEX), today announced that Qatar Investment Authority (“QIA”), the sovereign wealth fund of the State of Qatar, through its affiliates, has agreed to acquire a minority interest in AIT, the world’s largest provider of factory automation to the aerospace, defense, and space launch sectors. The transaction is expected to close in 2022, subject to regulatory conditions and approvals.

QIA will acquire its interest in AIT through a combination of primary capital and partial sales by the company’s two existing shareholders, AIT’s founding management team and Onex Partners IV. Following the transaction, all three parties will assume minority joint ownership of the company.

“QIA is among the world’s most sophisticated investors. We’ve been deliberate in our choice of partner and are excited for this next chapter in our history,” commented Ed Chalupa, AIT’s Founder, Chairman and Chief Executive Officer. “AIT is emerging from the pandemic with the highest quality contracted backlog in its history. Our ability to attract high quality investors is testament to the critical role automation technology is playing in restoring factory production rates, easing cost pressures and enabling industry product launches after a two-year pandemic disruption.”

Mr. Mansoor bin Ebrahim Al-Mahmoud, Chief Executive Officer of QIA, said: “We continue to target value added growth businesses in automation and productivity enhancing industries globally. We’re excited to partner with AIT, as it looks to address demand post pandemic, while exploring new avenues for innovation in space launch and urban air mobility.”

About AIT
Headquartered in Plano, TX, Advanced Integration Technology (“AIT”) is the world’s largest provider of automation, factory integration and tooling solutions dedicated to the global aerospace, defense, and space launch vehicle industries, as well as new manufacturing solutions for commercial urban air mobility markets. AIT serves a wide range of global, blue-chip OEMs and Tier 1 suppliers, including Airbus, Boeing, Lockheed Martin, Northrop Grumman, and Spirit AeroSystems. AIT has facilities in the United States, Canada, Spain, and Sweden. For more information on AIT, visit its website at www.aint.com.

About QIA
Qatar Investment Authority (“QIA”) is the sovereign wealth fund of the State of Qatar. QIA was founded in 2005 to invest and manage the state reserve funds. QIA is among the largest and most active sovereign wealth funds globally. QIA invests across a wide range of asset classes and regions as well as in partnership with leading institutions around the world to build a global and diversified investment portfolio with a long-term perspective that can deliver sustainable returns and contribute to the prosperity of the State of Qatar. For more information on QIA, visit its website at www.qia.qa.

About Onex
Founded in 1984, Onex manages and invests capital on behalf of its shareholders, institutional investors and high net worth clients from around the world. Onex’ platforms include: Onex Partners, private equity funds focused on mid- to large-cap opportunities in North America and Western Europe; ONCAP, private equity funds focused on middle market and smaller opportunities in North America; Onex Credit, which manages primarily non-investment grade debt through tradeable, private and opportunistic credit strategies as well as actively managed public equity and public credit funds; and Gluskin Sheff’s wealth management services. In total, as of September 30, 2021, Onex has approximately $47 billion of assets under management, of which approximately $7.9 billion is its own investing capital. With offices in Toronto, New York, New Jersey, Boston and London, Onex and its experienced management teams are collectively the largest investors across Onex’ platforms.

Onex shares trade on the Toronto Stock Exchange under the stock symbol ONEX. For more information on Onex, visit its website at www.onex.com. Onex’ security filings can also be accessed at www.sedar.com.

Advisors
Morgan Stanley & Co. LLC and Citigroup Global Markets Inc. are serving as financial advisors to AIT and Fried, Frank, Harris, Shriver & Jacobson LLP and White & Case LLP are serving as its legal advisors. Sullivan & Cromwell LLP is serving as legal advisor to QIA.

Forward-Looking Statements
This press release may contain, without limitation, statements concerning possible or assumed future operations, performance or results preceded by, followed by or that include words such as “believes”, “expects”, “potential”, “anticipates”, “estimates”, “intends”, “plans” and words of similar connotation, which would constitute forward-looking statements. Forward-looking statements are not guarantees. The reader should not place undue reliance on forward-looking statements and information because they involve significant and diverse risks and uncertainties that may cause actual operations, performance or results to be materially different from those indicated in these forward-looking statements. Except as may be required by Canadian securities law, Onex is under no obligation to update any forward-looking statements contained herein should material facts change due to new information, future events or other factors. These cautionary statements expressly qualify all forward-looking statements in this press release.

For Further Information:

AIT
Michael Wellham
President & COO
Michael.Wellham@aint.com
QIA
Media@qia.qa
Onex
Jill Homenuk
Managing Director – Shareholder Relations and Communications
Tel: +1 416.362.7711
Categories
MENA Pakistan Press Releases

Bombardier Appoints Christophe Degoumois as Executive Advisor

Accomplished sales leader will provide strategic insight as Bombardier grows its customer base

MONTREAL, Feb. 22, 2022 (GLOBE NEWSWIRE) — Bombardier is pleased to announce the appointment of Christophe Degoumois, a former senior sales leader with the company, to the role of independent Executive Advisor, assisting the management team in strategic projects.

Mr. Degoumois, who until recently was Vice President, Sales, International, at Bombardier, has over 17 years of experience with the company, and played a key role in instilling its customer-centric culture.

“The business aviation industry continues to perform well and to attract interest from around the world,” said Eric Martel, President and Chief Executive Officer, Bombardier. “Christophe will bring valuable strategic insight to our leadership team as Bombardier executes its plan toward 2025 growth objectives, in this new era as a company focused on designing, delivering and servicing the world’s best business jets.”

Bombardier’s leading portfolio of Challenger and Global business jets is well positioned to meet a growing demand for business aviation. Bombardier aircraft are sought-after around the world thanks to their performance, unmatched cabin experience and smooth ride.

About Bombardier

Bombardier is a global leader in aviation, focused on designing, manufacturing and servicing the world’s most exceptional business jets. Bombardier’s Challenger and Global aircraft families are renowned for their cutting-edge innovation, cabin design, performance and reliability. Bombardier has a worldwide fleet of approximately 5,000 aircraft in service with a wide variety of multinational corporations, charter and fractional ownership providers, governments and private individuals. Bombardier aircraft are also trusted around the world in special-mission roles.

Headquartered in Montréal, Québec, Bombardier operates aerostructure, assembly and completion facilities in Canada, the United States and Mexico. The company’s robust customer support network includes facilities in strategic locations in the United States and Canada, as well as in the United Kingdom, Germany, France, Switzerland, Italy, Austria, the UAE, Singapore, China and an Australian facility opening in 2022.

For corporate news and information, including Bombardier’s Environmental, Social and Governance report, visit bombardier.com. Learn more about Bombardier’s industry-leading products and customer service network at businessaircraft.bombardier.com. Follow us on Twitter @Bombardier.

Bombardier, Challenger and Global are registered or unregistered trademarks of Bombardier Inc or its subsidiaries.

For Information
Louise Solomita
Bombardier
514-855-5001, ext. 25148
Louise.Solomita@aero.bombardier.com

Categories
MENA Pakistan Press Releases

Resolve Systems Announces Middle East Expansion with Opening of Dubai Office

Supports Partner and Enterprise Customers on their IT Automation Journeys

DUBAI, UAE, Feb. 22, 2022 /PRNewswire/ — Resolve Systems®, the leading intelligent IT automation software vendor, today announced its expansion into the Middle East to support organizations on their IT automation journeys. The newly established office located in Dubai will serve customers and partners in the Middle East region including UAE, Saudi Arabia, Egypt, Qatar, Kuwait, Oman, Bahrain, Jordan, Lebanon, Turkey and Pakistan, as well as Africa.

Resolve Systems

“Resolve’s rapid growth reflects the recognized strength and value of our IT automation solutions as the pace of digital transformation accelerates around the globe,” said Vijay Kurkal, CEO, Resolve Systems. “We are excited to establish this in-region presence to serve and support enterprises and IT service providers across the Middle East and Africa, as they look to adopt intelligent tools that will provide greater visibility into their IT systems and enable automation for many of their IT operations processes.”

Resolve’s expansion comes amid rising demand for automation technology as digital transformation initiatives continue to advance across this region. IT automation has emerged as an essential tool to help overcome challenges including the global IT talent shortage. And as a key element of the digital transformation journey which has been prioritized in response to the pandemic, Resolve expects adoption of its intelligent IT automation solutions to accelerate rapidly in the coming year.

Resolve’s Amer Sharkawi, Regional Sales Director, and Mohamad Ashokaibi, Senior Sales Engineer, will lead the Dubai office.

“Organizations across the Middle East, Turkey, and Africa are increasing their efforts around IT automation to find the best strategies for today’s digital world,” commented Sharkawi. “We look forward to working closely with our existing partners and customers in the region and developing new relationships to extend the benefits of our powerful solutions.”

To contact a Resolve Systems Middle East representative visit https://resolve.io/about-us/contact.

About Resolve Systems

Resolve Systems helps enterprise technology teams worldwide achieve agile, autonomous operations with an industry-leading intelligent IT automation platform. With more than a decade of automation expertise, Resolve’s solutions are purpose-built to address challenges posed by increasing IT complexity. Resolve enables organizations to maximize operational efficiency, overcome labor shortages, reduce costs, quickly troubleshoot and fix problems, and accelerate service delivery. Resolve is majority-owned by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software companies.

Learn more at resolve.io, follow us on Twitter @ResolveSystems and LinkedIn, and tune into Intelligent Automation Radio for insights on the impact and opportunities for innovation that automation delivers, on our website, or wherever you get your podcasts.

Logo – https://mma.prnewswire.com/media/1749845/Resolve_Logo.jpg